B. Cedermark

Plasma pharmacokinetics of adriamycin after intrapleural administration

S. Eksborg, A. Lindfors, B. Cedermark, 1984, Medical oncology and tumor pharmacotherapy.

Intrahepatic and intravenous administration of adriamycin—A Comparative pharmacokinetic study in patients with malignant liver tumours

S. Eksborg, H. S. Strandler, B. Cedermark, 1985, Medical oncology and tumor pharmacotherapy.

Mab 17-1A Used for Therapy of Patients with Metastatic Colorectal Carcinomas

B. Ahlman, J. Shetye, U. Harmenberg, 1989 .

The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma

J. Shetye, U. Harmenberg, P. Biberfeld, 1989, Medical oncology and tumor pharmacotherapy.

High dose rDNA human alpha 2 interferon therapy in patients with advanced colorectal adenocarcinoma: a phase II study.

H. Blomgren, T. Theve, C. Silfverswärd, 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (Trial 1) and in combination with 5-fluorouracil (Trial 2) in advanced colorectal cancer

H. Blomgren, R. Reznek, P. Clark, 1987, International Journal of Colorectal Disease.

Oral treatment with RU 41.740 (Biostim) in patients with advanced colorectal cancer: influence on the blood lymphocyte population.

H. Blomgren, T. Theve, U. Ohman, 1989, International journal of immunopharmacology.